We are live on ! Find out more
SMMT icon

Summit Therapeutics

37 hedge funds and large institutions have $42.9M invested in Summit Therapeutics in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 5

110% more capital inflows, than outflows

Capital inflows: $10.7M | Capital outflows: $5.07M

95% more funds holding

Funds holding: 19 → 37 (+18)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

1.59% more ownership

Funds ownership: 9.5% → 11.09% (+1.6%)

Holders
37
Holders Change
+18
Holders Change %
+94.74%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
5
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SMMT Hedge Fund Activity: Q4 2020 in Review

37 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q4 2020, worth a combined $42.9M — up 59% from $27M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new SMMT positions and 5 closed out — a net gain of 18 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Polar Capital Holdings, adding an estimated $3.39M. The largest seller was JP Morgan Chase, cutting an estimated $4.54M.

  • 37 institutional investors held Summit Therapeutics (SMMT) as of Q4 2020, up from 19 in Q3 2020.
  • Funds reported $42.9M of Summit Therapeutics stock for Q4 2020, up 59% quarter-over-quarter.
  • 23 funds opened new Summit Therapeutics positions in Q4 2020 and 5 closed out, a net change of +18 holders.
  • The largest Summit Therapeutics buyer in Q4 2020 was Polar Capital Holdings, an estimated $3.39M added.
  • The largest Summit Therapeutics seller in Q4 2020 was JP Morgan Chase, an estimated $4.54M sold.

Based on aggregated 13F filings for Q4 2020.